ArticleFrontiers in endocrinology2022

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus.

Xiaodie Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.